Range
- - -
Vol / Avg.
-/559.7K
Div / Yield
-
52 Wk
56.95 - 93.66
Mkt Cap
7.4B
Payout Ratio
-
Open
-
P/E
-
EPS
-0.61
Shares
104.5M
Outstanding
104.5M
Total Float
89.3M
Benzinga - Sep 28, 2021, 7:36AM
load more
Sector: Health Care.Industry: Biotechnology
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting hepatitis B, Alpha-1 Antitrypsin Deficiency, thrombosis and angioedema, clear-cell and renal cell carcinoma, and cardiovascular disease.

Earnings

see more
Q1 2022Est.ActualSurprise
EPS
(EXPECTED)2022-02-03
REV
Q4 2021Est.ActualSurprise
EPS-0.100-0.610 -0.5100
REV56.770M38.283M-18.487M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Arrowhead Pharmaceuticals Questions & Anwsers

Q

How do I buy Arrowhead Pharmaceuticals (ARWR) stock?

A

You can purchase shares of Arrowhead Pharmaceuticals (NASDAQ: ARWR) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Arrowhead Pharmaceuticals's (ARWR) competitors?

Q

What is the target price for Arrowhead Pharmaceuticals (ARWR) stock?

A

The latest price target for Arrowhead Pharmaceuticals (NASDAQ: ARWR) was reported by SVB Leerink on November 23, 2021. The analyst firm set a price target for 45.00 expecting ARWR to fall to within 12 months (a possible -36.77% downside). 8 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Arrowhead Pharmaceuticals (ARWR)?

A

The stock price for Arrowhead Pharmaceuticals (NASDAQ: ARWR) is $71.17 last updated Mon Nov 29 2021 21:00:03 GMT+0000 (Coordinated Universal Time).

Q

Does Arrowhead Pharmaceuticals (ARWR) pay a dividend?

A

There are no upcoming dividends for Arrowhead Pharmaceuticals.

Q

When is Arrowhead Pharmaceuticals (NASDAQ:ARWR) reporting earnings?

A

Arrowhead Pharmaceuticals’s $Q1 earnings are confirmed for after-market on February 3, 2022.

Q

Is Arrowhead Pharmaceuticals (ARWR) going to split?

A

There is no upcoming split for Arrowhead Pharmaceuticals.

Q

What sector and industry does Arrowhead Pharmaceuticals (ARWR) operate in?

A

Arrowhead Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.